Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Haematologica|October 24, 2024
Pathogenesis and inflammaging in myelodysplastic syndromeMatthew T Villaume, Michael R Savona
World Journal of Oncology|June 5, 2020
Dural Marginal Zone Lymphoma in a Patient With a Hepatitis C Virus InfectionMatthew T Villaume, Dilan Patel, Christine Lopez, et al.
Angewandte Chemie (International Ed. in English)|August 14, 2014
One-pot enzymatic synthesis of merochlorin A and BRobin Teufel, Leonard Kaysser, Matthew T Villaume, et al.
Haematologica|August 18, 2022
Selective inhibition of MCL1 overcomes venetoclax resistance in a murine model of myelodysplastic syndromesMelissa A Fischer, Yuanbin Song, Maria P Arrate, et al.
ACS Central Science|May 11, 2016
Antroquinonol A: Scalable Synthesis and Preclinical Biology of a Phase 2 Drug CandidateMatthew T Villaume, Eran Sella, Garrett Saul, et al.
Experimental Hematology|February 22, 2021
The delta isoform of phosphatidylinositol-3-kinase predominates in chronic myelomonocytic leukemia and can be targeted effectively with umbralisib and ruxolitinibMatthew T Villaume, M Pia Arrate, Haley E Ramsey, et al.
Blood Advances|February 12, 2020
Venetoclax response is enhanced by selective inhibitor of nuclear export compounds in hematologic malignanciesMelissa A Fischer, Sharon Y Friedlander, Maria P Arrate, et al.
Biorxiv : the Preprint Server for Biology|July 29, 2026
Specific F1 ATP synthase inhibition delivers transient mitochondrial stress for selective targeting of acute myeloid leukemiaMatthew T Villaume, Haley E Ramsey, Valeria Impedovo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 10, 2023
PI3K Inhibition Restores and Amplifies Response to Ruxolitinib in Patients with MyelofibrosisTamara K Moyo, Ashwin Kishtagari, Matthew T Villaume, et al.
Pageof 1